Current methods for accurately monitoring intracranial pressure (ICP) require invasive procedures, limiting continuous monitoring to in-hospital settings and posing risks of infection and other complications. This makes it difficult to detect ICP changes outside of the hospital, hindering early intervention and disease surveillance for conditions like hydrocephalus, traumatic brain injury, and brain tumors. A limited understanding of ICP dynamics and treatment response further complicates effective management.

SensoBrain is developing a minimally invasive sensor technology for continuous, long-term ICP monitoring, enabling real-time data collection both during and after hospitalization. The sensor is designed to be implanted during surgery or in a sub-acute setting, recording measurements that are then uploaded to a secure cloud for analysis. By identifying patient-specific ICP patterns through AI and machine learning, SensoBrain aims to facilitate earlier diagnosis, reduce patient morbidity, and potentially decrease mortality. The technology provides healthcare professionals with summary reports, emergency notifications, and insights to optimize workflow and improve patient engagement.

Minimally invasive sensor for continuous intracranial pressure (ICP) monitoring

Measures and records ICP during and post-hospitalization

Data uploaded to a secure cloud for analysis

AI and machine learning algorithms for identifying patient-specific ICP patterns

Emergency notification system for critical ICP events

Summary reports for healthcare professional review

Designed for long-term ambulatory sensing of ICP

Electronics and power-free design

MRI compatible and biocompatible materials

The primary target audience includes neurologists, neurosurgeons, and other healthcare professionals involved in the management of patients with conditions such as hydrocephalus, traumatic brain injury, brain tumors, and chronic headaches, as well as patients at risk of elevated ICP.